Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Irritable Bowel Syndrome, April 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 74 articles:
HTML format


 

Single Articles

  1. SALEHI B, Sharifi-Rad R, Sharopov F, Namiesnik J, et al
    Beneficial effects and potential risks of tomato consumption for human health: An overview.
    Nutrition. 2019;62:201-208.
    Abstract    

    Abstract available

  2. PRECUP G, Vodnar DC
    Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles-A comprehensive literature review.
    Br J Nutr. 2019 Mar 29:1-24. doi: 10.1017/S0007114519000680.
    Abstract    

    Abstract available

  3. CHEN HD, Bair MJ, Chang WC, Hsu CS, et al
    Similarities and differences between IBS-C and FC with regards to symptomatology, sleep quality and psychological attributes.
    J Formos Med Assoc. 2019 Mar 25. pii: S0929-6646(18)30667.
    Abstract    

    Abstract available

  4. QIN HY, Zang KH, Zuo X, Wu XA, et al
    Quercetin Attenuates Visceral Hypersensitivity and 5-Hydroxytryptamine Availability in Postinflammatory Irritable Bowel Syndrome Rats: Role of Enterochromaffin Cells in the Colon.
    J Med Food. 2019 Mar 28. doi: 10.1089/jmf.2018.4264.
    Abstract    

    Abstract available

  5. RANJBAR S, Seyednejad SA, Nikfar S, Rahimi R, et al
    How can we develop better antispasmodics for irritable bowel syndrome?
    Expert Opin Drug Discov. 2019 Mar 28:1-14. doi: 10.1080/17460441.2019.1593369.
    Abstract    

    Abstract available

  6. YANG J, Shang B, Shi H, Zhu S, et al
    The role of toll-like receptor 4 and mast cell in the ameliorating effect of electroacupuncture on visceral hypersensitivity in rats.
    Neurogastroenterol Motil. 2019 Mar 27:e13583. doi: 10.1111/nmo.13583.
    Abstract    

    Abstract available

  7. DU X, Allwood G, Webberley KM, Inderjeeth AJ, et al
    Noninvasive Diagnosis of Irritable Bowel Syndrome via Bowel Sound Features: Proof of Concept.
    Clin Transl Gastroenterol. 2019;10:e00017.
    Abstract    

    Abstract available

  8. MISERY L, Cochener B, Brenaut E, Seite S, et al
    Association of sensitive skin with sensitive corneas and sensitive eyelids.
    J Eur Acad Dermatol Venereol. 2019 Mar 23. doi: 10.1111/jdv.15595.
    Abstract    

    Abstract available

  9. ZHU HM, Li L, Li SY, Yan Q, et al
    Effect of water extract from Berberis heteropoda Schrenk roots on diarrhea-predominant irritable bowel syndrome by adjusting intestinal flora.
    J Ethnopharmacol. 2019;237:182-191.
    Abstract    

    Abstract available

  10. WILSON B, Rossi M, Dimidi E, Whelan K, et al
    Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials.
    Am J Clin Nutr. 2019 Apr 4. pii: 5428039. doi: 10.1093.
    Abstract    

    Abstract available

  11. HOWELL CA, Mikhalovsky SV, Markaryan EN, Khovanov AV, et al
    Investigation of the adsorption capacity of the enterosorbent Enterosgel for a range of bacterial toxins, bile acids and pharmaceutical drugs.
    Sci Rep. 2019;9:5629.
    Abstract    

    Abstract available

  12. HUDON THIBEAULT AA, Sanderson JT, Vaillancourt C
    Serotonin-estrogen interactions: what can we learn from pregnancy?
    Biochimie. 2019 Apr 1. pii: S0300-9084(19)30100.
    Abstract    

    Abstract available

  13. MARCINIAK TA, Serebruany V
    Should We Use Tegaserod for Irritable Bowel Syndrome?
    Am J Ther. 2019 Mar 29. doi: 10.1097/MJT.0000000000000947.
    Abstract    

    Abstract available

  14. CHELIMSKY GG, Yang S, Sanses T, Tatsuoka C, et al
    Autonomic neurophysiologic implications of disorders comorbid with bladder pain syndrome vs myofascial pelvic pain.
    Neurourol Urodyn. 2019 Apr 4. doi: 10.1002/nau.23995.
    Abstract    

    Abstract available

  15. FISHER E, Law E, Dudeney J, Eccleston C, et al
    Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents.
    Cochrane Database Syst Rev. 2019;4:CD011118.
    Abstract    

    Abstract available

  16. JOHANNESSON E, Jakobsson Ung E, Ringstrom G, Sadik R, et al
    The experiences of physical activity in Irritable Bowel Syndrome - A qualitative study.
    J Clin Nurs. 2019 Apr 2. doi: 10.1111/jocn.14880.
    Abstract    

    Abstract available

  17. FISHER K, Hutcheon D, Ziegler J
    Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review.
    Nutr Clin Pract. 2019 Apr 1. doi: 10.1002/ncp.10269.
    Abstract    

    Abstract available

  18. FU R, Chen M, Chen Y, Mao G, et al
    Expression and clinical significance of 5-HT and 5-HT3R in the intestinal mucosa of patient with diarrhea-type irritable bowel syndrome.
    Exp Ther Med. 2019;17:3077-3082.
    Abstract    

    Abstract available

  19. NOZU T, Miyagishi S, Nozu R, Takakusaki K, et al
    Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
    Eur J Pharmacol. 2019;852:198-206.
    Abstract    

    Abstract available

  20. OOI SL, Correa D, Pak SC
    Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?
    Complement Ther Med. 2019;43:73-80.
    Abstract    

    Abstract available

  21. BAJ A, Moro E, Bistoletti M, Orlandi V, et al
    Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  22. MARTIN R, Chamignon C, Mhedbi-Hajri N, Chain F, et al
    The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response.
    Sci Rep. 2019;9:5398.
    Abstract    

    Abstract available

  23. NAN J, Yang W, Meng P, Huang W, et al
    Changes of the postcentral cortex in irritable bowel syndrome patients.
    Brain Imaging Behav. 2019 Mar 29. pii: 10.1007/s11682-019-00087.
    Abstract    

    Abstract available

  24. SAILER M
    [Slow Transit Constipation].
    Zentralbl Chir. 2019;144:179-189.
    Abstract    

    Abstract available

  25. ERDOGAN Z, Kurcer MA
    Dietary Supplement Use in Gastrointestinal Symptom Management and Effect on Hopelessness Levels in Patients With Irritable Bowel Syndrome.
    Holist Nurs Pract. 2019;33:155-162.
    Abstract    

    Abstract available

  26. ELMALIKLIS IN, Liveri A, Ntelis B, Paraskeva K, et al
    Increased Functional Foods' Consumption and Mediterranean Diet Adherence May Have a Protective Effect in the Appearance of Gastrointestinal Diseases: A Case(-)Control Study.
    Medicines (Basel). 2019;6.
    Abstract    

    Abstract available

  27. OZAN ZT, Tanik N, Inan LE
    Constipation is associated with tension type headache in women.
    Arq Neuropsiquiatr. 2019;77:161-165.
    Abstract    

    Abstract available

  28. MADISCH A
    [Gluten-free diet and low FODMAP diet: no or minor evidence for treating irritable bowel syndrome].
    Z Gastroenterol. 2019;57:518-519.
    Abstract    



  29. DRUMMOND J
    Functional Nutrition Treatment of Vulvodynia, Irritable Bowel Syndrome, and Depression: A Case Report.
    Integr Med (Encinitas). 2018;17:44-51.
    Abstract    

    Abstract available

  30. DONG J, Liang W, Wang T, Sui J, et al
    Saponins regulate intestinal inflammation in colon cancer and IBD.
    Pharmacol Res. 2019 Apr 5. pii: S1043-6618(18)31961.
    Abstract    

    Abstract available

  31. WANG Z, Xu CM, Liu YX, Wang XQ, et al
    Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Chin Med J (Engl). 2019;132:889-904.
    Abstract    

    Abstract available

  32. BALLOU S, Katon J, Singh P, Rangan V, et al
    Chronic Diarrhea and Constipation are More Common in Depressed Individuals.
    Clin Gastroenterol Hepatol. 2019 Apr 4. pii: S1542-3565(19)30362.
    Abstract    

    Abstract available

  33. BAO C, Noga H, Allaire C, Williams C, et al
    Provoked Vestibulodynia in Women with Pelvic Pain.
    Sex Med. 2019 Apr 3. pii: S2050-1161(19)30030-3. doi: 10.1016/j.esxm.2019.
    Abstract    

    Abstract available

  34. RADU M, Baban A, Dumitrascu DL
    Reply.
    J Gastrointestin Liver Dis. 2019;28:132-133.
    Abstract    



  35. FLACCO ME, Manzoli L, De Giorgio R, Gasbarrini A, et al
    Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis.
    Eur Rev Med Pharmacol Sci. 2019;23:2986-3000.
    Abstract    

    Abstract available

  36. JEONG SJ
    The Role of Fecal Calprotectin in Pediatric Disease.
    Korean J Pediatr. 2019 Mar 28. pii: kjp.2019.00059. doi: 10.3345/kjp.2019.00059.
    Abstract    

    Abstract available

  37. WONG HLX, Qin HY, Tsang SW, Zuo X, et al
    Early life stress disrupts intestinal homeostasis via NGF-TrkA signaling.
    Nat Commun. 2019;10:1745.
    Abstract    

    Abstract available

  38. PIACENTINO D, Cesarini M, Badiali D, Pallotta N, et al
    The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome.
    Riv Psichiatr. 2019;54:75-83.
    Abstract    

    Abstract available

  39. LAI HC, Lin YW, Hsieh CL
    Acupuncture-Analgesia-Mediated Alleviation of Central Sensitization.
    Evid Based Complement Alternat Med. 2019;2019:6173412.
    Abstract    

    Abstract available

  40. LV PR, Su YS, He W, Wang XY, et al
    Electroacupuncture Alleviated Referral Hindpaw Hyperalgesia via Suppressing Spinal Long-Term Potentiation (LTP) in TNBS-Induced Colitis Rats.
    Neural Plast. 2019;2019:2098083.
    Abstract    

    Abstract available

  41. FOND G
    [Syndrome de l'intestin irritable : de la comorbidite anxiodepressive au microbiote].
    Rev Prat. 2019;69:219-220.
    Abstract    



  42. BOUCHOUCHA M, Fysekidis M, Rompteaux P, Airinei G, et al
    Influence of Age and Body Mass Index on Total and Segmental Colonic Transit Times in Constipated Subjects.
    J Neurogastroenterol Motil. 2019;25:258-266.
    Abstract    

    Abstract available

  43. TAN TK, Saps M, Lin CL, Wei CC, et al
    Is Long-term Ambient Air Pollutant Exposure a Risk Factor for Irritable Bowel Syndrome in Children? A 12-year Longitudinal Cohort Study.
    J Neurogastroenterol Motil. 2019;25:241-249.
    Abstract    

    Abstract available

  44. NAM K, Shin JE
    Can Certain Foods Cause Gastrointestinal Symptoms in Korean Patients With Irritable Bowel Syndrome?
    J Neurogastroenterol Motil. 2019;25:179-180.
    Abstract    



  45. WYLEZINSKI LS, Gray JD, Polk JB, Harmata AJ, et al
    Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes.
    J Clin Med. 2019;8.
    Abstract    

    Abstract available

  46. MUNJAL A, Dedania B, Cash B
    Update on Pharmacotherapy for Irritable Bowel Syndrome.
    Curr Gastroenterol Rep. 2019;21:25.
    Abstract    

    Abstract available

  47. GHOSH G, Jesudian AB
    Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.
    J Clin Exp Hepatol. 2019;9:257-267.
    Abstract    

    Abstract available

  48. FROLUND PEDERSEN H, Holsting A, Frostholm L, Rask C, et al
    "Understand your illness and your needs": Assessment-informed patient education for people with multiple functional somatic syndromes.
    Patient Educ Couns. 2019 Apr 17. pii: S0738-3991(18)30768.
    Abstract    

    Abstract available

  49. KLINE L
    The Flavone Luteolin, an Endocrine Disruptor, Relaxed Male Guinea Pig Gallbladder Strips.
    Gastroenterology Res. 2019;12:53-59.
    Abstract    

    Abstract available

  50. LACY BE, Harris LA, Chang L, Lucak S, et al
    Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.
    Therap Adv Gastroenterol. 2019;12:1756284819841290.
    Abstract    

    Abstract available

  51. SZYMASZKIEWICZ A, Malkiewicz A, Storr M, Fichna J, et al
    The place of tachykinin NK2 receptor antagonists in the treatment diarrhea-predominant irritable bowel syndrome.
    J Physiol Pharmacol. 2019;70.
    Abstract    

    Abstract available

  52. KADDUMI E
    Effect of Distal Esophageal Irritation on the Changes of Cystometry Parameters to Esophagus and Colon Distentions in Rats.
    Can J Physiol Pharmacol. 2019 Apr 23. doi: 10.1139/cjpp-2019-0122.
    Abstract    

    Abstract available

  53. JOSEFSSON A, Rosendahl A, Jerlstad P, Naslin G, et al
    Visceral sensitivity remains stable over time in patients with irritable bowel syndrome, but with individual fluctuations.
    Neurogastroenterol Motil. 2019 Apr 22:e13603. doi: 10.1111/nmo.13603.
    Abstract    

    Abstract available

  54. PANARESE A, Pesce F, Porcelli P, Riezzo G, et al
    Chronic functional constipation is strongly linked to vitamin D deficiency.
    World J Gastroenterol. 2019;25:1729-1740.
    Abstract    

    Abstract available

  55. JONES MP, Faresjo A, Beath A, Faresjo T, et al
    Abdominal Pain in Children Develops With Age and Increases With Psychosocial Factors.
    Clin Gastroenterol Hepatol. 2019 Apr 19. pii: S1542-3565(19)30426.
    Abstract    

    Abstract available

  56. SHIH YS, Tsai CH, Li TC, Lai HC, et al
    The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
    J Ethnopharmacol. 2019 Apr 19:111889. doi: 10.1016/j.jep.2019.111889.
    Abstract    

    Abstract available

  57. HOLSTER S, Lindqvist CM, Repsilber D, Salonen A, et al
    The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.
    Clin Transl Gastroenterol. 2019 Apr 15. doi: 10.14309/ctg.0000000000000034.
    Abstract    

    Abstract available

  58. HOLLISTER EB, Oezguen N, Chumpitazi BP, Luna RA, et al
    Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome.
    J Mol Diagn. 2019 Apr 15. pii: S1525-1578(18)30235.
    Abstract    

    Abstract available

  59. BOND A, Probert C
    Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply.
    Aliment Pharmacol Ther. 2019;49:1087-1088.
    Abstract    



  60. KESHTELI AH, Madsen KL, Mandal R, Boeckxstaens GE, et al
    Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply.
    Aliment Pharmacol Ther. 2019;49:1088-1089.
    Abstract    



  61. LEONG RWL, Kaakoush NO, Yau YY, Wasinger VC, et al
    Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission-confounded by the gut microbiome?
    Aliment Pharmacol Ther. 2019;49:1086-1087.
    Abstract    



  62. XU D, Chen VL, Steiner CA, Berinstein JA, et al
    Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2019 Mar 20. doi: 10.14309/ajg.0000000000000198.
    Abstract    

    Abstract available

  63. NOORAFSHAN A, Yousefi M, Hosseini L, Karbalay-Doust S, et al
    Can Sertraline and Nortriptyline Protect the Neurons in Submucosal and Myenteric Plexuses of Rat's Colon Against Stress?
    Dig Dis Sci. 2019 Apr 1. pii: 10.1007/s10620-019-05600.
    Abstract    

    Abstract available

  64. ORHURHU VJ, Roberts JS, Cohen SP, Li H, et al
    Assessment of the Quality and Content of Clinical Practice Guidelines on Irritable Bowel Syndrome Using the AGREE II Instrument.
    Digestion. 2019 Apr 10:1-11. doi: 10.1159/000499838.
    Abstract    

    Abstract available

  65. SU H, Li YT, Heitkemper MM, Zia J, et al
    Effects of Low-FODMAPS Diet on Irritable Bowel Syndrome Symptoms and Gut Microbiome.
    Gastroenterol Nurs. 2019;42:150-158.
    Abstract    

    Abstract available

  66. VARNEY J, Muir JG, Gibson PR
    Prebiotics Versus Low FODMAP Diet: An Interpretative Nightmare.
    Gastroenterology. 2019;156:1222.
    Abstract    



  67. PITTAYANON R, Lau JT, Yuan Y, Leontiadis GI, et al
    Gut Microbiota in Patients With Irritable Bowel Syndrome-a Systematic Review.
    Gastroenterology. 2019 Mar 30. pii: S0016-5085(19)34649.
    Abstract    

    Abstract available

  68. SIMREN M, Tornblom H, Palsson OS, Van Oudenhove L, et al
    Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome.
    Gastroenterology. 2019 Apr 22. pii: S0016-5085(19)36712.
    Abstract    

    Abstract available

  69. EVERITT HA, Landau S, O'Reilly G, Sibelli A, et al
    Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial.
    Gut. 2019 Apr 10. pii: gutjnl-2018-317805. doi: 10.1136/gutjnl-2018-317805.
    Abstract    

    Abstract available

  70. PARIDA PK, Mishra D, Pati GK, Nath P, et al
    A prospective study on incidence, risk factors, and validation of a risk score for post-infection irritable bowel syndrome in coastal eastern India.
    Indian J Gastroenterol. 2019 Apr 4. pii: 10.1007/s12664-019-00943.
    Abstract    

    Abstract available

  71. HALMOS EP, Gibson PR
    Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome.
    J Gastroenterol Hepatol. 2019 Mar 8. doi: 10.1111/jgh.14650.
    Abstract    

    Abstract available

  72. NORLIN AK, Faresjo A, Falk M, Jones MP, et al
    Primary healthcare utilisation and self-rated health among patients with Irritable Bowel Syndrome: What are the impacts of comorbidities, gastrointestinal symptom burden, sense of coherence and stress?
    J Psychosom Res. 2019;119:1-7.
    Abstract    

    Abstract available

  73. PETERSEN MW, Schroder A, Jorgensen T, Ornbol E, et al
    RIFD - A brief clinical research interview for functional somatic disorders and health anxiety.
    J Psychosom Res. 2019 Apr 2. pii: S0022-3999(19)30045.
    Abstract    

    Abstract available

  74. LE NEVE B, Derrien M, Tap J, Brazeilles R, et al
    Fasting breath H2 and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome.
    PLoS One. 2019;14:e0214273.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;